AkerJBeckMPapayJI. Consumers better understand and prefer simplified written drug information: an evaluation of 2 novel formats versus the current CMI. Therapeutic Innovation & Regulatory Science. 2013;47(1):125–132.
3.
BuiDNakamuraCBrayBEZeng-TreitlerQ. Automated illustration of patients instructions. AMIA Annu Symp Proc. 2012;2012:1158–1167.
4.
ChanAHChanKW. Effects of prospective-user factors and sign design features on guessability of pharmaceutical pictograms. Patient Educ Couns. 2013;90(2):268–275.
5.
DowseRRamelaTBarfordKBrowneS. Developing visual images for communicating information about antiretroviral side effects to a low-literate population. Afr J AIDS Res. 2010;9(3):213–224.
6.
KassamRVaillancourtLRCollinsJB. Pictographic instructions for medications: do different cultures interpret them accurately?Int J Pharm Pract. 2004;12(4):199–209.
7.
RaynorDKDickinsonD. Key principles to guide development of consumer medicine information—content analysis of information design texts. Ann Pharmacother. 2009;43(4):700–706.
8.
ShrankWAvornJRolonCShekelleP. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783–801.
9.
WilsonEAWolfMS. Working memory and the design of health materials: a cognitive factors perspective. Patient Educ Couns. 2009;74(3):318–322.
10.
WolfMSDavisTCBassPF. Improving prescription drug warnings to promote patient comprehension. Arch Int Med. 2010;170(1):50–56.
